Primary CNS lymphoma: Difference between revisions
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
[[HIV neurologic complications]] | *[[HIV neurologic complications]] | ||
==Evaluation== | ==Evaluation== | ||
*CT scan: well-defined focal lesion, isodense or hyperdense to the gray matter | *CT scan: well-defined focal lesion, isodense or hyperdense to the gray matter | ||
Revision as of 05:59, 5 May 2017
Background
- AIDS defining malignancy that is strongly related to Epstein-Barr virus (EBV) infection
- Occurs with profound immunosuppression (CD4 counts <50cells/uL)
- Accounts for approximately 20 to 30% of CNS lesions in patients with AIDs
Clinical Features
- Can present with a variety of focal or nonfocal signs and symptoms
- Confusion, lethargy, memory loss, hemiparesis, aphasia, mental status changes, seizures
- Constitutional symptoms (systemic B symptoms)
Differential Diagnosis
Evaluation
- CT scan: well-defined focal lesion, isodense or hyperdense to the gray matter
- MRI scan (higher diagnostic yield): variable, isointense or hypointense lesions on T1-weighted images
- Lumbar puncture:
- CSF cytology
- CSF EBV PCR
- Should also obtain toxoplasma serologies, most are treated empirically for toxoplasma while serology is pending
- Stereotactic brain biopsy if necessary
Management
- High-dose methotrexate therapy (3 g/m2 for four to eight cycles)
- Steroids
- Potent antiretroviral therapy
- Radiation therapy
